BioCentury
ARTICLE | Financial News

GenSight Biologics completes IPO

July 18, 2016 7:00 AM UTC

GenSight Biologics S.A. (Euronext:SIGHT), Paris, France Business: Ophthalmic Date completed: 2016-07-12 Type: IPO Raised: EUR40 million ($44.1 million) Shares: 5 million Price: EUR8 Shares after offer...